二十家中国科技公司、生物医学公司和制造业公司向新加坡的全球投资者投诚,凸显了对中国资产的新兴趣。 Twenty Chinese tech, biomed, and manufacturing firms pitched to global investors in Singapore, highlighting renewed interest in Chinese assets.

在新加坡举行的中国-新加坡跨界投资和融资会议使20个A级上市的中国技术公司、生物医学公司和先进制造业公司汇聚一堂,与国际投资者接触。 The China-Singapore Cross-Border Investment and Financing Conference in Singapore brought together 20 A-share listed Chinese firms in tech, biomedicine, and advanced manufacturing to pitch to international investors. 这次活动由中国公共公司协会和中国银行新加坡分行共同主办,突出了全球对中国资产的新兴趣,列举了强大的经济基本要素、政策稳定性和技术股票的回升。 Co-hosted by the China Association for Public Companies and Bank of China Singapore Branch, the event highlighted renewed global interest in Chinese assets, citing strong economic fundamentals, policy stability, and a rebound in tech stocks. Huatai证券组织第三年,强调其扩大的跨界范围,包括在印度颁发SGX问题经理许可证和外国证券投资登记。 Huatai Securities, organizing for the third year, emphasized its expanded cross-border reach, including an SGX Issue Manager license and FPI registration in India. 讨论的重点是“新加坡+1”、可持续投资和技术一体化等战略,目的是加强全球资本与高质量中国公司之间的长期联系。 Discussions focused on strategies like “Singapore+1,” sustainable investment, and technology integration, aiming to strengthen long-term ties between global capital and high-quality Chinese companies.